Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;238(3):e13975.
doi: 10.1111/apha.13975. Epub 2023 Apr 30.

L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways

Su Li  1   2   3 , Muyin Liu  1 , Jinxiang Chen  1 , Yuqiong Chen  4 , Ming Yin  1 , You Zhou  1   2   3 , Qiyu Li  1 , Fei Xu  1 , Youran Li  1 , Xiaopei Yan  4 , Yan Xia  1   2   3 , Ao Chen  1   2   3 , Danbo Lu  1   2   3 , Chenguang Li  1   2   3 , Li Shen  1   2   3 , Zhangwei Chen  1   2   3 , Juying Qian  1   2   3 , Junbo Ge  1   2   3
Affiliations

L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways

Su Li et al. Acta Physiol (Oxf). 2023 Jul.

Abstract

Aim: To explore the beneficial effects of L-carnitine on cardiac microvascular dysfunction in diabetic cardiomyopathy from the perspectives of mitophagy and mitochondrial integrity.

Methods: Male db/db and db/m mice were randomly assigned to groups and were treated with L-carnitine or a solvent for 24 weeks. Endothelium-specific PARL overexpression was attained via adeno-associated virus serotype 9 (AAV9) transfection. Adenovirus (ADV) vectors overexpressing wild-type CPT1a, mutant CPT1a, or PARL were transfected into endothelial cells exposed to high glucose and free fatty acid (HG/FFA) injury. Cardiac microvascular function, mitophagy, and mitochondrial function were analyzed by immunofluorescence and transmission electron microscopy. Protein expression and interactions were assessed by western blotting and immunoprecipitation.

Results: L-carnitine treatment enhanced microvascular perfusion, reinforced endothelial barrier function, repressed the endothelial inflammatory response, and maintained the microvascular structure in db/db mice. Further results demonstrated that PINK1-Parkin-dependent mitophagy was suppressed in endothelial cells suffering from diabetic injury, and these effects were largely alleviated by L-carnitine through the inhibition of PARL detachment from PHB2. Moreover, CPT1a modulated the PHB2-PARL interaction by directly binding to PHB2. The increase in CPT1a activity induced by L-carnitine or amino acid mutation (M593S) enhanced the PHB2-PARL interaction, thereby improving mitophagy and mitochondrial function. In contrast, PARL overexpression inhibited mitophagy and abolished all the beneficial effects of L-carnitine on mitochondrial integrity and cardiac microvascular function.

Conclusion: L-carnitine treatment enhanced PINK1-Parkin-dependent mitophagy by maintaining the PHB2-PARL interaction via CPT1a, thereby reversing mitochondrial dysfunction and cardiac microvascular injury in diabetic cardiomyopathy.

Keywords: L-carnitine; PARL; PHB2; cardiac microvascular dysfunction; diabetes mellitus; mitophagy.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Kunadian V, Chieffo A, Camici PG, et al. An EAPCI expert consensus document on Ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by coronary vasomotor disorders international study group. Eur Heart J. 2020;41(37):3504-3520.
    1. Horton WB, Barrett EJ. Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr Rev. 2021;42(1):29-55.
    1. Feenstra RGT, Boerhout CKM, Woudstra J, et al. Presence of coronary endothelial dysfunction, coronary vasospasm, and adenosine-mediated Vasodilatory disorders in patients with ischemia and nonobstructive coronary arteries. Circ Cardiovasc Interv. 2022;15(8):e012017.
    1. Zhou H, Wang S, Zhu P, Hu S, Chen Y, Ren J. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission. Redox Biol. 2018;15:335-346.
    1. Sun D, Wang J, Toan S, et al. Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance. Angiogenesis. 2022;25(3):307-329.

Publication types

LinkOut - more resources